Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Adenosine reuptake refers to the cellular process by which extracellular adenosine is transported back into cells via specific nucleoside transporters. This process regulates the concentration of adenosine in the extracellular space, thereby modulating its physiological effects. Inhibition of adenosine reuptake enhances endogenous protective mechanisms mediated by elevated extracellular adenosine levels, with potential therapeutic applications in ischemic diseases, neurological disorders, and inflammation.
Inhibition of adenosine transporters (e.g., ENT1), leading to increased extracellular adenosine concentrations and enhanced adenosine receptor activation.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Adenosine Reuptake.